Acknowledgments The author is grateful to the Department of Biotechnology, Middle East Technical University, Turkey, for providing the necessary facilities during PhD program and many thanks to the Department of Biology, Kocaeli University and TUBTAK (grant No
As we were enjoying the positive human infusion data and anticipating a major effort to design both protease resistant GLP-1 analogues and an inhibitor of the responsible protease as new diabetes therapies, I was shocked when told that senior Pfizer leadership had concluded that there would never be another injectable therapy for diabetes other than insulin. To view or add a comment, sign in More Relevant Posts FDA July 2026 New Drug Therapy Approval A New Step Forward in Kidney Disease Treatment
Starting July 1, 2026, the Medicare GLP-1 Bridge gives eligible Humana members weight-loss access to Wegovy at $50 per month and Humana is the CMS-selected central processor for that Bridge program
PubMed This article is for educational and research purposes only
10.1038/s41540-022-00261-6 42 FlorezJ
Features Benefits: Colour details: How to use: Full lip: Gradation lip: 1